Recent Finacing
Recent Raise
GeneCentric develops GenomicsNext, an integrated liquid‑biopsy platform combining ctDNA variant detection and ExpressCT-derived gene‑expression measurements, plus rT(I)ME Explorer and AI tools to identify oncology responder signatures for biopharma collaborations.
